Article 2. Interpretation of terms
Law 105/2016/QH13 — Luật Dược số 105/2016/QH13
General provisions
In this Law, the terms below are construed as follows:
1. Pharmaceuticals include drugs and drug materials.
2. Drug means a preparation containing a pharmaceutical ingredient or medicinal materials for the purpose of prevention, diagnosis, cure, treatment or mitigation of human diseases or modification of physiological functions of the human body. Drugs include pharmacochemical drugs, drugs made from medicinal materials, traditional drugs, vaccines and biological products.
3. Drug materials means components forming a drug, including pharmaceutical ingredients, medicinal materials, adjuvants and capsules used in the course of drug manufacture.
4. Pharmaceutical ingredient (also called active ingredient) means a substance or mixture of substances used to manufacture a drug and having pharmacological effects or direct effects in the prevention, diagnosis, cure, treatment or mitigation of disease or in the modification of physiological functions of the human body.
5. Medicinal materials means drug materials which are derived from plant, animal or mineral origin and satisfy drug manufacture standards.
6. Pharmacochemical drug means a drug containing a pharmaceutical ingredient of identified composition, formula and purity and satisfying drug manufacture standards. Pharmacochemical drugs also include injection drugs which are extracted from medicinal materials and drugs combining pharmaceutical ingredients with medicinal materials which have been proven to be safe and effective.
7. Drug from medicinal materials means a drug composed of medicinal materials and having its effects supported by scientific evidence, except traditional drugs mentioned in Clause 8 of this Article.
8. Traditional drug (including also traditional medicament) means a drug composed of medicinal materials which are processed, prepared or blended according to traditional medicine theories and methods or according to folk experiences into a product with a traditional or modern form.
9. Traditional medicament means medicinal materials prepared according to traditional medicine theories and methods and used to manufacture a traditional drug or to prevent and treat disease.
10. Biological product (also called bio-drug) means a drug manufactured by a bio-technology or bio-process from a polymeric substance or mixture of polymeric substances of biological origin, including also human blood and plasma derivatives.
Biological products do not include antibiotics, low-molecular-weight substances of biological origin which can be isolated as pure substances, and in vitro diagnostic biological products.
11. Reference biological product (also called reference bio-drug) means a biological product permitted for circulation in Vietnam on the basis of sufficient data on its quality, safety and efficacy.
12. Similar biological product (also called similar bio-drug) means a biological product whose quality, safety and efficacy are similar to those of a reference bio-drug.
13. Vaccine means a drug containing antigens which induce an immune response in the human body, and used to treat and cure disease.
14. New drug means a drug containing a new pharmaceutical ingredient or medicinal materials used for the first time as a drug in Vietnam; or a drug with a new combination of a pharmaceutical ingredient already in circulation or of medicinal materials previously used as drugs in Vietnam.
15. Generic drug means a drug having the same pharmaceutical ingredient, content and formulation with those of a brand name specific and usually used as a substitute for the brand name specific.
16. Brand name specific means a drug first licensed for circulation on the basis of sufficient data on its quality, safety and efficacy.
17. Habit-forming drug means a drug containing pharmaceutical ingredients with neural stimulation or inhibition effects which can easily cause addiction to users, and included in the list of habit-forming drugs promulgated by the Minister of Health.
18. Psychotropic drug means a drug containing pharmaceutical ingredients with neural stimulation or inhibition effects or causing hallucination, having the potential to induce a state of addiction when used consistently, and included in the list of psychotropic drugs issued by the Minister of Health.
19. Pre-substance drug means a drug containing a pre-substance included in the list of pre-substances used as drugs issued by the Minister of Health.
20. Combination drug containing a habit-forming pharmaceutical ingredient means a drug containing many active ingredients including a habit-forming active ingredient with a concentration or content prescribed by the Minister of Health.
21. Combination drug containing a psychotropic pharmaceutical ingredient means a drug containing many active ingredients including a psychotropic active ingredient with a concentration or content prescribed by the Minister of Health.
22. Combination drug containing a pre-substance means a drug containing many pharmaceutical ingredients including a pre-substance with a concentration or content prescribed by the Minister of Health.
23. Radioactive drug means a drug containing a radioactive nuclear component used to diagnose and cure diseases in humans or to conduct biomedical research, including radioisotopes or radioisotopes combined with a tracer.
24. Radioisotope means an isotope of a chemical element whose atom has an unstable nucleus that emits ionizing radiation in the process of decay to become stable following the emission.
25. Tracer (also called label) means a substance or compound used for preparation and combination with a radioisotope to form a radioactive drug.
26. Drugs and drug materials under special control (below referred to as drugs under special control for short) include:
a/ Drugs defined in Clauses 17, 18, 19, 20, 21, 22, 23 and 24 of this Article;
b/ Drug materials that are psychotropic pharmaceutical ingredients, habit-forming substances, pre-substances used as drugs or radioactive substances for drug manufacture defined in Clauses 17, 18, 19, 20, 21, 22, 23 and 24 of this Article;
c/ Toxic drugs and toxic drug materials on the list promulgated by the Minister of Health;
d/ Drugs and pharmaceutical materials on the list of substances banned from use in a number of specific sectors and fields as prescribed by the Government.
27. Non-prescription drug mean a drug that can be dispensed, retailed and used without a prescription and is included in the list of non-prescription drugs promulgated by the Minister of Health.
28. Prescription drug means a drug that can be dispensed, retailed and used only with a prescription. Such a drug may be dangerous to the user’s life or health if it is used not in accordance with the prescription.
29. Essential drug means a drug that satisfies the healthcare demand of a vast majority of people and is included in the list of essential drugs issued by the Minister of Health.
30. Rare drug means a drug used to prevent, diagnose and cure a rare disease, or a drug which is not always available as prescribed by the Minister of Health.
31. Shelf life of a drug means the period predetermined for a drug after which the drug must not be used.
Shelf life of a drug shall be expressed either as a period of time computed from the date of manufacture to the date of expiry or as a specific expiry date (day, month and year). In case the expiry date is indicated only in month and year, the shelf life will last until the last day of the month of expiry.
32. Substandard drug means a drug that fails to satisify the quality standards registered with a competent state agency.
33. Counterfeit drug means a drug manufactured in one of the following cases:
a/ It does not have any pharmaceutical ingredients or medicinal materials;
b/ It has pharmaceutical ingredients other than those shown on its label or failing to satisfy the standards registered for circulation or stated in its import permit;
c/ It has pharmaceutical ingredients or medicinal materials with a concentration or content or an amount inconsistent with that registered for circulation or stated in its import permit, except drugs that fail to satisfy quality standards as prescribed in Clause 32 of this Article in the course of preservation, circulation or distribution;
d/ It is manufactured, displayed or labeled in a way counterfeiting a genuine manufacturer, a country of manufacture or a country of origin.
34. Counterfeit medicinal materials means medicinal materials in one of the following cases:
a/ They are not derived from the species, parts or origin intentionally shown by the trading establishment on their labels or in accompanying documents;
b/ They are intentionally mixed with or replaced by ingredients other than medicinal materials shown on their labels or mixed with or replaced by medicinal ingredients intentionally extracted from active ingredients;
c/ They are manufactured, displayed or labeled in a way to counterfeit a manufacturer, a country of manufacture or a country of origin.
35. Adverse reactions of a drug means undesirable harmful effects of a drug which may occur with a normal dose.
36. Pharmacy practice means the use by a person of his/her professional qualifications to do drug business and conduct clinical pharmacy activities.
37. Good practices means a set of principles and standards on the manufacture, preservation, testing or circulation of drugs, prescription of drugs, clinical trial of drugs, and culture, cultivation and harvest of medicinal materials, and other sets of principles and standards promulgated or announced by the Minister of Health for application based on the instructions of the World Health Organization or other international organizations which are joined or accredited by Vietnam.
38. Bioavailability means a measurement of the rate and extent to which a pharmaceutical ingredient or active substance from a drug is absorbed into a living body and appears at the site of activity inside the body.
39. Bioequivalence means the similarity of bioavailability between two drugs when compared under the same testing condition.
40. Clinical pharmacy means the pharmaceutical scientific research and pharmacy pratice to provide advice on the rational, safe and effective use of a drug in order to optimize its use.
41. Pharmacovigilance means the detection, assessment and prevention of adverse effects related to the use of a drug.
42. Primary package of a drug means the package containing a drug, being in direct contact with the drug, and shaping the drug or tightly wrapping around the shape of the drug.
43. Drug business means the carrying out of one, a number or all of the stages of the investment process, from manufacture to sale of drugs or provision of services related to drugs and drug materials in the market for profit-making purposes.
Article 2, Law 105/2016/QH13